Imagion Biosystems Limited
IBXXF
$0.01
-$0.025-71.43%
| Weiss Ratings | IBXXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | IBXXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | IBXXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -- | |||
| Price History | IBXXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -- | |||
| 30-Day Total Return | -- | |||
| 60-Day Total Return | -- | |||
| 90-Day Total Return | -- | |||
| Year to Date Total Return | -- | |||
| 1-Year Total Return | -- | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -- | |||
| 52-Week Low % Change | -- | |||
| Price | IBXXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price (Date) | -- | |||
| Valuation | IBXXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | -- | |||
| Enterprise Value | 2.01M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.04 | |||
| Earnings Per Share Growth | -- | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -- | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | -- | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | IBXXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 57.27M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | IBXXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 61 3 9692 7222 | |||
| Address | Level 4 Melbourne, VIC 3205 | |||
| Website | imagionbiosystems.com | |||
| Country | Australia | |||
| Year Founded | 2016 | |||
| Profitability | IBXXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -27.99% | |||
| Profit Margin | -77.52% | |||
| Management Effectiveness | IBXXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -12.65% | |||
| Return on Equity | -- | |||
| Income Statement | IBXXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 1.76M | |||
| Total Revenue (TTM) | 1.76M | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | 1.49M | |||
| EBITDA (TTM) | -182.70K | |||
| EBIT (TTM) | -491.80K | |||
| Net Income (TTM) | -1.36M | |||
| Net Income Avl. to Common (TTM) | -1.36M | |||
| Total Revenue Growth (Q YOY) | -75.94% | |||
| Earnings Growth (Q YOY) | 88.73% | |||
| EPS Diluted (TTM) | -0.04 | |||
| EPS Diluted Growth (Q YOY) | 93.50% | |||
| Balance Sheet | IBXXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 1.65M | |||
| Cash Per Share (Q) | $0.03 | |||
| Total Current Assets (Q) | 1.72M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -1.41M | |||
| Current Ratio (Q) | 0.548 | |||
| Book Value Per Share (Q) | -$0.01 | |||
| Total Assets (Q) | 1.74M | |||
| Total Current Liabilities (Q) | 3.15M | |||
| Total Debt (Q) | 1.76M | |||
| Total Liabilities (Q) | 3.15M | |||
| Total Common Equity (Q) | -1.41M | |||
| Cash Flow | IBXXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 55.10K | |||
| Cash from Financing (TTM) | 2.39M | |||
| Net Change in Cash (TTM) | 1.61M | |||
| Levered Free Cash Flow (TTM) | -407.20K | |||
| Cash from Operations (TTM) | -839.30K | |||
